Metropolitan Life Insurance CO Cassava Sciences Inc Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$12.64 - $30.11 $3,197 - $7,617	-253 Reduced 10.0%	2,277 $51,000
Q3 2023 Nov 14, 2023	BUY	$16.64 - $25.32 $6,273 - $9,545	377 Added 17.51%	2,530 $42,000
Q1 2023 May 15, 2023	SELL	$23.46 - $36.44 $5,161 - $8,016	-220 Reduced 9.27%	2,153 $51,000
Q4 2022 Jun 14, 2023	BUY	$27.82 - $44.16 $6,120 - $9,715	220 Added 10.22%	2,373 $70.1 Million
Q3 2022 Jun 14, 2023	BUY	$16.33 - $51.06 $3,592 - $11,233	220 Added 10.22%	2,373 $99.2 Million
Q2 2022 Jun 20, 2023	BUY	$17.22 - $38.47 $3,788 - $8,463	220 Added 10.22%	2,373 $66,000
Q1 2022 Jun 20, 2023	BUY	$32.6 - $53.05 $7,172 - $11,671	220 Added 10.22%	2,373 $88,000
Q1 2022 Mar 30, 2023	SELL	$32.6 - $53.05 $274,198 - $446,203	-8,411 Reduced 78.0%	2,373 $88,000
Q1 2022 May 12, 2022	SELL	$32.6 - $53.05 $274,198 - $446,203	-8,411 Reduced 78.0%	2,373 $88,000
Q4 2021 Jun 21, 2023	BUY	$36.77 - $90.91 $317,361 - $784,644	8,631 Added 400.88%	10,784 $471,000
Q3 2021 Jun 21, 2023	BUY	$41.79 - $135.3 $360,689 - $1.17 Million	8,631 Added 400.88%	10,784 $669,000
Q3 2021 Mar 30, 2023	BUY	$41.79 - $135.3 $10,363 - $33,554	248 Added 2.35%	10,784 $669,000
Q3 2021 Nov 15, 2021	BUY	$41.79 - $135.3 $10,363 - $33,554	248 Added 2.35%	10,784 $669,000
Q2 2021 Jun 21, 2023	BUY	$32.15 - $89.72 $269,513 - $752,122	8,383 Added 389.36%	10,536 $900,000
Q2 2021 Mar 30, 2023	BUY	$32.15 - $89.72 $45,460 - $126,864	1,414 Added 15.5%	10,536 $900,000
Q2 2021 Aug 16, 2021	BUY	$32.15 - $89.72 $338,443 - $944,482	10,527 Added 116966.67%	10,536 $900,000
Q1 2021 Jun 26, 2023	BUY	$7.09 - $87.95 $49,410 - $612,923	6,969 Added 323.69%	9,122 $410 Million
Q1 2021 Mar 30, 2023	SELL	$7.09 - $87.95 $14,073 - $174,580	-1,985 Reduced 17.87%	9,122 $410,000
Q1 2021 May 14, 2021	SELL	$7.09 - $87.95 $78,684 - $976,069	-11,098 Reduced 99.92%	9 $410,000
Q4 2020 Jun 22, 2023	BUY	$6.79 - $12.25 $60,797 - $109,686	8,954 Added 415.88%	11,107 $75,000
Q4 2020 Mar 30, 2023	BUY	$6.79 - $12.25 $59,303 - $106,991	8,734 Added 368.06%	11,107 $75,000
Q4 2020 Feb 16, 2021	BUY	$6.79 - $12.25 $75,416 - $136,060	11,107 New	11,107 $76,000

Others Institutions Holding SAVA

# of Institutions

207

Shares Held

14M

Call Options Held

2.98M

Put Options Held

6.57M

Black Rock Inc. New York, NY

3.22M
Shares

$8.85 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

2.52M
Shares

$6.94 Million
0.0% of portfolio
State Street Corp Boston, MA

1.16M
Shares

$3.2 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

1.01M
Shares

$2.77 Million
0.0% of portfolio
Gallacher Capital Management LLC Lone Tree, CO

580K
Shares

$1.6 Million
7.83% of portfolio

View Full List

About CASSAVA SCIENCES INC

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $110M
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

More about SAVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account